XPAX vs. BCSF, CVII, TRIN, CION, AACT, FSNB, ENGN, NETD, SCRM, and RRAC
Should you be buying Zalatoris II Acquisition stock or one of its competitors? The main competitors of Zalatoris II Acquisition include Bain Capital Specialty Finance (BCSF), Churchill Capital Corp VII (CVII), Trinity Capital (TRIN), CION Investment (CION), Ares Acquisition Co. II (AACT), Fusion Acquisition Corp. II (FSNB), enGene (ENGN), Nabors Energy Transition Corp. II (NETD), Screaming Eagle Acquisition (SCRM), and Rigel Resource Acquisition (RRAC). These companies are all part of the "holding & other investment offices" industry.
Zalatoris II Acquisition (NASDAQ:XPAX) and Bain Capital Specialty Finance (NYSE:BCSF) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings.
Bain Capital Specialty Finance received 57 more outperform votes than Zalatoris II Acquisition when rated by MarketBeat users.
Bain Capital Specialty Finance has a net margin of 43.42% compared to Zalatoris II Acquisition's net margin of 0.00%. Bain Capital Specialty Finance's return on equity of 12.64% beat Zalatoris II Acquisition's return on equity.
Bain Capital Specialty Finance has a consensus price target of $16.33, suggesting a potential downside of 2.72%. Given Bain Capital Specialty Finance's higher possible upside, analysts plainly believe Bain Capital Specialty Finance is more favorable than Zalatoris II Acquisition.
61.9% of Zalatoris II Acquisition shares are owned by institutional investors. 1.6% of Zalatoris II Acquisition shares are owned by company insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Bain Capital Specialty Finance had 6 more articles in the media than Zalatoris II Acquisition. MarketBeat recorded 6 mentions for Bain Capital Specialty Finance and 0 mentions for Zalatoris II Acquisition. Bain Capital Specialty Finance's average media sentiment score of 1.15 beat Zalatoris II Acquisition's score of 0.00 indicating that Bain Capital Specialty Finance is being referred to more favorably in the news media.
Zalatoris II Acquisition has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500. Comparatively, Bain Capital Specialty Finance has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.
Bain Capital Specialty Finance has higher revenue and earnings than Zalatoris II Acquisition.
Summary
Bain Capital Specialty Finance beats Zalatoris II Acquisition on 11 of the 13 factors compared between the two stocks.
Get Zalatoris II Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for XPAX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding XPAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zalatoris II Acquisition Competitors List
Related Companies and Tools
